Let us help you customize your experience.
Tell us a little about yourself so we can share more relevant content and resources.
This study will look at a new dry powder to be mixed with water before oral administration. The study medication is called rivaroxaban and it can be taken orally, as a liquid with the dose adjusted to the weight of your child.
Children from 6 months to 12 years of age will be enrolled in the study. You have been asked to have your child take part in this research study because he/she has been diagnosed and completed treatment for a blood clot.